Incyte (Nasdaq:INCY) is a drug discovery and development company focused on developing proprietary small molecule drugs to treat serious unmet medical needs.
Recent Mentions on Fool.com
- Why Incyte Corporation Shares Are Crashing Today
- Could CTI BioPharma's FDA Shortcut Spell Trouble for Incyte?
- This Small-Cap Biotech Could Wind Up Devouring a Much Larger Foe's Revenue Stream
- Are the 3 Best-Performing Big-Cap Biotech Stocks of 2015 Still Worth Buying?
- 3 Growth Stocks Near 52-Week Highs Worth Selling